Publikationen (34) Publikationen von JOSÉ ANTONIO GÓMEZ VIDAL

2024

  1. Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

    Nature Metabolism, Vol. 6, Núm. 10, pp. 1939-1962

2023

  1. Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 396, Núm. 6, pp. 1211-1222

2022

  1. Effectiveness of an O-Alkyl Hydroxamate in Dogs with Naturally Acquired Canine Leishmaniosis: An Exploratory Clinical Trial

    Animals, Vol. 12, Núm. 19

  2. In silico design of HDAC6 inhibitors with neuroprotective effects

    Journal of Biomolecular Structure and Dynamics, Vol. 40, Núm. 24, pp. 14204-14222

  3. New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production

    European Journal of Medicinal Chemistry, Vol. 237

  4. Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1909-1920

2021

  1. Modifications on the tetrahydroquinoline scaffold targeting a phenylalanine cluster on GPER as antiproliferative compounds against renal, liver and pancreatic cancer cells

    Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-19

  2. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

2020

  1. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines

    Scientific Reports, Vol. 10, Núm. 1

  2. O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity

    Journal of Medicinal Chemistry, Vol. 63, Núm. 11, pp. 5734-5751

2019

  1. A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis

    Pharmacological Research, Vol. 139, pp. 375-383

2018

  1. Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1

    Journal of Medicinal Chemistry, Vol. 61, Núm. 16, pp. 7144-7167

2017

  1. Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations

    Journal of Biomolecular Structure and Dynamics, Vol. 35, Núm. 13, pp. 2794-2814

2014

  1. Exploring the potential binding sites of some known HDAC inhibitors on some HDAC8 conformers by docking studies

    Applied Biochemistry and Biotechnology, Vol. 173, Núm. 7, pp. 1907-1926

  2. Production of the Phanerochaete flavido-alba laccase in Aspergillus niger for synthetic dyes decolorization and biotransformation

    World Journal of Microbiology and Biotechnology, Vol. 30, Núm. 1, pp. 201-211

  3. Synthesis of l -octaarginine through microencapsulated palladium-catalyzed allyl ester deprotection

    Synlett, Vol. 25, Núm. 16, pp. 2319-2322

2013

  1. Estudio de la estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua

    Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 10-14

2008

  1. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies

    Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 4, pp. 1457-1460

2007

  1. 5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation

    Medicinal Chemistry, Vol. 3, Núm. 3, pp. 233-239

  2. A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells

    Breast Cancer Research and Treatment, Vol. 105, Núm. 3, pp. 237-246